Alefacept

Therapeutic indications

Alefacept is indicated for:

Psoriasis

Population group: both men and women, only adults (18 years old or older)

Alefacept is indicated is indicated for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

15 mg given once weekly

7.5 mg given once weekly

Contraindications

Alefacept is contraindicated in the following cases:

HIV

at least one of
AIDS
Human immunodeficiency virus

Medication Recommendation

Receive personalized medication regimen for every patient case

Ask the Reasoner

< Previous: Overview
Next: Precautions >